Last reviewed · How we verify
NCT06903169: HHET
Understanding End User Preferences for Hand Hygiene Enabling Technologies in Urban and Peri-urban Lusaka Zambia
trial in Handwashing in 37 participants. Completed in 30 November 2023.
30 November 2023
Quick facts
| Lead sponsor | Centre for Infectious Disease Research in Zambia |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 37 |
| Start date | 1 October 2023 |
| Primary completion | 30 November 2023 |
| Estimated completion | 30 November 2023 |
| Sites | 1 location across Zambia |
Conditions studied
- Handwashing — all drugs for Handwashing →
Sponsor
Centre for Infectious Disease Research in Zambia — full company profile →
Who can join
18 and older, any sex, with Handwashing. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The goal of this study is to explore the perceived attributes, acceptability, and use of various improved handwashing facility designs. The study aimed to establish what are the characteristics of handwashing facilities (attributes) that are prioritized among various groups of potential end users and how do existing improved HWF designs rank according to these preferences? Also how acceptable are promising HWF designs among multiple groups of potential end users in a real-world setting, how do potential users adapt and modify existing HWF for use in their homes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06903169
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Centre for Infectious Disease Research in Zambia trials
Trials by the same sponsor.
- NCT07107516 — Phase 1b Ascending Dose Study of PanChol in Healthy Volunteers · Phase 1 · not yet recruiting
- NCT06903143 — Piloting a Biomarker-augmented Alcohol Screening, Brief Intervention, and Referral to Treatment (SBIRT) Program Among HI · NA · not yet recruiting
- NCT06503666 — Zambian Informed Motivated Aware Responsible Adolescent Girls and Adults · NA · recruiting
- NCT07021092 — PERSON-CENTERED APPROACHES TO VIREMIA: CONNECTION, RAPPORT, AND ENGAGEMENT STUDY · NA · recruiting
- NCT06904521 — OH Baseline Research Study · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06903169 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Centre for Infectious Disease Research in Zambia
- Last refreshed: 30 March 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06903169.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing